"ARTIOS (COMB157G23101) A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes (PRO) in patients with relapsing multiple sclerosis(RMS) transitioning from fumarate-based RMS approved therapies or fingolimod therapy"